Amphetamine challenge decreases yohimbine binding to α2 adrenoceptors in Landrace pig brain

Psychopharmacology

Volumn 222, Issue 1, 2012, Pages 155-163

  Landau, Anne M ^a   Doudet, Doris J ^a,b   Jakobsen, Steen ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

2 Adrenoceptor; Amphetamine; Animal model; Catecholamine; Monoamine; Neuroimaging; Neurotransmitter release; Noradrenaline; Noradrenergic; Norepinephrine; Pig; Positron emission tomography; Receptor binding; Yohimbine

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; AMPHETAMINE; NORADRENALIN; UNCLASSIFIED DRUG; YOHIMBINE; YOHIMBINE C 11;

ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CAUDATE NUCLEUS; CEREBELLUM; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FEMALE; FRONTAL CORTEX; LANDRACE; NEUROIMAGING; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; NORADRENALIN RELEASE; OCCIPITAL CORTEX; PONS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; SWINE; SYNAPSE; TEMPORAL CORTEX; THALAMUS;

ADRENERGIC ALPHA-2 RECEPTOR ANTAGONISTS; AMPHETAMINE; ANIMALS; BRAIN; CARBON RADIOISOTOPES; FEMALE; NOREPINEPHRINE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTORS, ADRENERGIC, ALPHA-2; SWINE; TISSUE DISTRIBUTION; YOHIMBINE;

EID: 84861880601     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2632-6     Document Type: Article

References (57)

1. Agarwal RK, Chandna VK, Engelking LR, Lightbown K, Kumar MS (1993) Distribution of catecholamines in the central nervous system of the pig. Brain Res Bull 32:285-291 (Pubitemid 23210282)
2. Alhassoon OM, Dupont RM, Schweinsburg BC, Taylor MJ, Patterson TL, Grant I (2001) Regional cerebral blood flow in cocaineversus methamphetamine-dependent patients with a history of alcoholism. Int J Neuropsychopharmacol 4:105-112 (Pubitemid 32587376)
3. Alstrup AKO, Jakobsen S, Wegener G, Hansen AK, Doudet DJ, Landau AM (2010) Anesthesia in animal imaging: differing effects of propofol vs isoflurane on DA D1 receptor binding in Gottingen minipig brain. Neuroimage: S181
4. Arponen E, Helin S, Marjamaki P, Gronroos T, Nagren K, Ingman K, Haaparanta M, Sallinen J, Solin O (2010) Radiosynthesis of a new alpha-2C-adrenoceptor tracer [11C]ORM-13070 and its preclinical evaluation in rats. NeuroImage 52(suppl 1):S125
5. Biaggioni I, Robertson RM, Robertson D (1994) Manipulation of norepinephrine metabolism with yohimbine in the treatment of autonomic failure. J Clin Pharmacol 34:418-423 (Pubitemid 24154144)
6. Bjorklund A, Divac I, Lindvall O (1978) Regional distribution of catecholamines in monkey cerebral cortex, evidence for a dopaminergic innervation of the primate prefrontal cortex. Neurosci Lett 7:115-119 (Pubitemid 8306959)
7. Chan GL, Holden JE, Stoessl AJ, Doudet DJ, Wang Y, Dobko T, Morrison KS, Huser JM, English C, Legg B, Schulzer M, Calne DB, Ruth TJ (1998) Reproducibility of the distribution of carbon-11-SCH 23390, a dopamine D1 receptor tracer, in normal subjects. J Nucl Med 39:792-797 (Pubitemid 28216725)
8. Cho SS, Strafella AP (2009) rTMS of the left dorsolateral prefrontal cortex modulates dopamine release in the ipsilateral anterior cingulate cortex and orbitofrontal cortex. PLoS One 4:e6725
9. Clarke RW, Harris J (2002) RX 821002 as a tool for physiological investigation of alpha(2)-adrenoceptors. CNS Drug Rev 8:177-192 (Pubitemid 34874384)
10. Cornil CA, Ball GF (2008) Interplay among catecholamine systems: dopamine binds to alpha2-adrenergic receptors in birds and mammals. J Comp Neurol 511:610-627
11. de la Fuente-Fernandez R, Sossi V, Huang Z, Furtado S, Lu JQ, Calne DB, Ruth TJ, Stoessl AJ (2004) Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias. Brain 127:2747-2754 (Pubitemid 39627382)
12. Dennis T, L'Heureux R, Carter C, Scatton B (1987) Presynaptic alpha- 2 adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in vivo dialysis) in the rat. J Pharmacol Exp Ther 241:642-649 (Pubitemid 17111575)
13. Devoto P, Flore G, Pira L, Longu G, Gessa GL (2004) alpha2- Adrenoceptor mediated co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex. J Neurochem 88:1003-1009 (Pubitemid 38199322)
14. Devoto P, Flore G, Saba P, Fa M, Gessa GL (2005) Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex. J Neurochem 92:368-374 (Pubitemid 40194027)
15. Devous MD Sr, Trivedi MH, Rush AJ (2001) Regional cerebral blood flow response to oral amphetamine challenge in healthy volunteers. J Nucl Med 42:535-542 (Pubitemid 32298269)
16. Doxey JC, Lane AC, Roach AG, Virdee NK (1984) Comparison of the alpha-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine and corynanthine. Naunyn Schmiedebergs Arch Pharmacol 325:136-144 (Pubitemid 14169919)
17. Drevets WC, Price JC, Kupfer DJ, Kinahan PE, Lopresti B, Holt D, Mathis C (1999) PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum. Neuropsychopharmacology 21:694-709
18. Drevets WC, Gautier C, Price JC, Kupfer DJ, Kinahan PE, Grace AA, Price JL, Mathis CA (2001) Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol Psychiatry 49:81-96 (Pubitemid 32119502)
19. Endres CJ, Kolachana BS, Saunders RC, Su T, Weinberger D, Breier A, Eckelman WC, Carson RE (1997) Kinetic modeling of [11C] raclopride: combined PET-microdialysis studies. J Cereb Blood Flow Metab 17:932-942 (Pubitemid 27396581)
20. Freedman JE, Aghajanian GK (1984) Idazoxan (RX 781094) selectively antagonizes alpha 2-adrenoceptors on rat central neurons. Eur J Pharmacol 105:265-272 (Pubitemid 14024440)
21. Gallezot JD, Weinzimmer D, Nabulsi N, Lin SF, Fowles K, Sandiego C, McCarthy TJ, Maguire RP, Carson RE, Ding YS (2011) Evaluation of [(11)C]MRB for assessment of occupancy of norepinephrine transporters: studies with atomoxetine in non-human primates. NeuroImage 56:268-279
22. Ginovart N, Hassoun W, Le Cavorsin M, Veyre L, Le Bars D, Leviel V (2002) Effects of amphetamine and evoked dopamine release on [11C]raclopride binding in anesthetized cats. Neuropsychopharmacology 27:72-84 (Pubitemid 34626744)
23. Gobert A, Rivet JM, Cistarelli L, Melon C, Millan MJ (1997) alpha2-Adrenergic receptor blockade markedly potentiates duloxetineand fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats. J Neurochem 69:2616-2619 (Pubitemid 27495451)
24. Gobert A, Billiras R, Cistarelli L, Millan MJ (2004) Quantification and pharmacological characterization of dialysate levels of noradrenaline in the striatum of freely-moving rats: release from adrenergic terminals and modulation by alpha2-autoreceptors. J Neurosci Methods 140:141-152 (Pubitemid 39625862)
25. Gonzalez AM, Pascual J, Meana JJ, Barturen F, del Arco C, Pazos A, Garcia-Sevilla JA (1994) Autoradiographic demonstration of increased alpha 2-adrenoceptor agonist binding sites in the hippocampus and frontal cortex of depressed suicide victims. J Neurochem 63:256-265 (Pubitemid 24184926)
26. Hassoun W, Le CavorsinM, Ginovart N, Zimmer L, Gualda V, Bonnefoi F, Leviel V (2003) PET study of the [11C]raclopride binding in thestriatum of the awake cat: effects of anaesthetics and role of cerebral blood flow. Eur J Nucl Med Mol Imaging 30:141-148 (Pubitemid 36692906)
27. Jakobsen S, Pedersen K, Smith DF, Jensen SB, Munk OL, Cumming P (2006) Detection of alpha2-adrenergic receptors in brain of living pig with 11C-yohimbine. J Nucl Med 47:2008-2015 (Pubitemid 47544989)
28. Jones SR, Gainetdinov RR, Wightman RM, Caron MG (1998) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci 18:1979-1986 (Pubitemid 28141404)
29. Kimmerly DS, Tutungi E, Wilson TD, Serrador JM, Gelb AW, Hughson RL, Shoemaker JK (2003) Circulating norepinephrine and cerebrovascular control in conscious humans. Clin Physiol Funct Imaging 23:314-319 (Pubitemid 37455607)
30. Kjaer TW, Bertelsen C, Piccini P, Brooks D, Alving J, Lou HC (2002) Increased dopamine tone during meditation-induced change of consciousness. Brain Res Cogn Brain Res 13:255-259 (Pubitemid 34212051)
31. Kovachich GB, Frazer A, Aronson CE (1993) Effect of chronic administration of antidepressants on alpha 2-adrenoceptors in the locus coeruleus and its projection fields in rat brain determined by quantitative autoradiography. Neuropsychopharmacology 8:57-65 (Pubitemid 23011158)
32. Laruelle M (2000) Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab 20:423-451
33. Lind NM, Olsen AK, Moustgaard A, Jensen SB, Jakobsen S, Hansen AK, Arnfred SM, Hemmingsen RP, Gjedde A, Cumming P (2005) Mapping the amphetamine-evoked dopamine release in the brain of the Gottingen minipig. Brain Res Bull 65:1-9 (Pubitemid 40186926)
34. Linnet J, Moller A, Peterson E, Gjedde A, Doudet D (2011) Dopamine release in ventral striatum during Iowa Gambling Task performance is associated with increased excitement levels in pathological gambling. Addiction 106:383-390
35. Logan J, Volkow ND, Fowler JS, Wang GJ, Dewey SL, MacGregor R, Schlyer D, Gatley SJ, Pappas N, King P et al (1994) Effects of blood flow on [11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data. J Cereb Blood Flow Metab 14:995-1010
36. MacDonald E, Scheinin M (1995) Distribution and pharmacology of alpha 2-adrenoceptors in the central nervous system. J Physiol Pharmacol 46:241-258
37. Mathew RJ, Wilson WH (1989) Changes in cerebral blood flow and mental state after amphetamine challenge in schizophrenic patients. Neuropsychobiology 21:117-123 (Pubitemid 20039673)
38. McCormick PN, Ginovart N, Wilson AA (2011) Isoflurane anaesthesia differentially affects the amphetamine sensitivity of agonist and antagonist D2/D3 positron emission tomography radiotracers: implications for in vivo imaging of dopamine release. Mol Imaging Biol 13:737-746
39. Millan MJ, Newman-Tancredi A, Audinot V, Cussac D, Lejeune F, Nicolas JP, Coge F, Galizzi JP, Boutin JA, Rivet JM, Dekeyne A, Gobert A (2000) Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states. Synapse 35:79-95
40. Narendran R, Frankle WG, Mason NS, Rabiner EA, Gunn RN, Searle GE, Vora S, Litschge M, Kendro S, Cooper TB, Mathis CA, Laruelle M (2009) Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride. Synapse 63:447-461
41. Newman-Tancredi A, Nicolas JP, Audinot V, Gavaudan S, Verriele L, Touzard M, Chaput C, Richard N, Millan MJ (1998) Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 358:197-206
42. Ordway GA, Schenk J, Stockmeier CA, May W, Klimek V (2003) Elevated agonist binding to alpha2-adrenoceptors in the locus coeruleus in major depression. Biol Psychiatry 53:315-323 (Pubitemid 36175545)
43. Polesskaya O, Silva J, Sanfilippo C, Desrosiers T, Sun A, Shen J, Feng C, Polesskiy A, Deane R, Zlokovic B, Kasischke K, Dewhurst S (2011) Methamphetamine causes sustained depression in cerebral blood flow. Brain Res 1373:91-100
44. Price JC, Drevets WC, Ruszkiewicz J, Greer PJ, Villemagne VL, Xu L, Mazumdar S, Cantwell MN, Mathis CA (2002) Sequential H(2) (15)O PET studies in baboons: before and after amphetamine. J Nucl Med 43:1090-1100 (Pubitemid 34847934)
45. Ressler KJ, Nemeroff CB (2000) Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety 12(Suppl 1):2-19
46. Riccardi P, Li R, Ansari MS, Zald D, Park S, Dawant B, Anderson S, Doop M, Woodward N, Schoenberg E, Schmidt D, Baldwin R, Kessler R (2006) Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans. Neuropsychopharmacology 31:1016-1026
47. Rose SE, Janke AL, Strudwick MW, McMahon KL, Chalk JB, Snyder P, De zubicaray GI (2006) Assessment of dynamic susceptibility contrast cerebral blood flow response to amphetamine challenge: a human pharmacological magnetic resonance imaging study at 1.5 and 4 T. Magn Reson Med 55:9-15 (Pubitemid 43062922)
48. Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, Partilla JS (2001) Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39:32-41
49. Schou M, Halldin C, Sovago J, Pike VW, Gulyas B, Mozley PD, Johnson DP, Hall H, Innis RB, Farde L (2003) Specific in vivo binding to the norepinephrine transporter demonstrated with the PET radioligand, (S, S)-[11C]MeNER. Nucl Med Biol 30:707-714
50. Smith DF, Dyve S, Minuzzi L, Jakobsen S, Munk OL, Marthi K, Cumming P (2006) Inhibition of [11C]mirtazapine binding by alpha2-adrenoceptor antagonists studied by positron emission tomography in living porcine brain. Synapse 59:463-471
51. Sossi V, Holden JE, Topping GJ, Camborde ML, Kornelsen RA, McCormick SE, Greene J, Studenov AR, Ruth TJ, Doudet DJ (2007) In vivo measurement of density and affinity of the monoamine vesicular transporter in a unilateral 6-hydroxydopamine rat model of PD. J Cereb Blood Flow Metab 27:1407-1415 (Pubitemid 46985355)
52. Subhash MN, Nagaraja MR, Sharada S, Vinod KY (2003) Cortical alpha-adrenoceptor downregulation by tricyclic antidepressants in the rat brain. Neurochem Int 43:603-609 (Pubitemid 36929814)
53. Tsukada H, Nishiyama S, Kakiuchi T, Ohba H, Sato K, Harada N, Nakanishi S (1999) Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain. Brain Res 849:85-96
54. Tyacke RJ, Robinson ES, Lalies MD, Hume SP, Hudson AL, Nutt DJ (2005) Estimation of endogenous noradrenaline release in rat brain in vivo using [3H]RX 821002. Synapse 55:126-132 (Pubitemid 39665671)
55. Uhlen S, Lindblom J, Johnson A,Wikberg JE (1997) Autoradiographic studies of central alpha 2A- and alpha 2C-adrenoceptors in the rat using [3H]MK912 and subtype-selective drugs. Brain Res 770:261-266
56. Uhlen S, Dambrova M, Nasman J, Schioth HB, Gu Y, Wikberg-Matsson A, Wikberg JE (1998) [3H]RS79948-197 binding to human, rat, guinea pig and pig alpha2A-, alpha2B- and alpha2C-adrenoceptors. Comparison with MK912, RX821002, rauwolscine and yohimbine. Eur J Pharmacol 343:93-101
57. van der Staay FJ, Pouzet B, Mahieu M, Nordquist RE, Schuurman T (2009) The d-amphetamine-treated Gottingen miniature pig: an animal model for assessing behavioral effects of antipsychotics. Psychopharmacology (Berl) 206:715-729